Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

Apr 20, 2022

SELL
$0.54 - $2.74 $25,758 - $130,698
-47,700 Closed
0 $0
Q4 2021

Jan 25, 2022

BUY
$2.33 - $3.37 $111,141 - $160,749
47,700 New
47,700 $104,000
Q3 2021

Oct 19, 2021

SELL
$2.52 - $2.99 $158,760 - $188,370
-63,000 Closed
0 $0
Q2 2021

Jul 23, 2021

BUY
$2.6 - $3.65 $163,800 - $229,950
63,000 New
63,000 $171,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $385M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.